Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Molecular Carcinogenesis (59:11) - New York, NY : Wiley - S. 1256-1268
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Technische Universität Berlin
- (wann)
-
2020
- Urheber
-
Sarif, Zina
Tolksdorf, Beatrice
Fechner, Henry
Eberle, Jürgen
- DOI
-
10.14279/depositonce-11064
- Handle
-
11303/12189
- URN
-
urn:nbn:de:101:1-2020122300590810876735
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sarif, Zina
- Tolksdorf, Beatrice
- Fechner, Henry
- Eberle, Jürgen
- Technische Universität Berlin
Entstanden
- 2020
Ähnliche Objekte (12)
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
MCL.
Targeting MDSC-mediated immunosuppression in melanoma
Anti- cancer therapy: Blazing the trail with melanoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
MCXLI. - MCL.
Selecting inflation indicators under an inflation targeting regime: evidence from the MCL method
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
Drug targeting organ specific strategies
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1
Cold atmospheric plasma as adjuvant in melanoma treatment targeting mitochondria
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
MCL.
Targeting MDSC-mediated immunosuppression in melanoma
Anti- cancer therapy: Blazing the trail with melanoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
MCXLI. - MCL.
Selecting inflation indicators under an inflation targeting regime: evidence from the MCL method
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
Drug targeting organ specific strategies
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1
Cold atmospheric plasma as adjuvant in melanoma treatment targeting mitochondria
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
MCL.
Targeting MDSC-mediated immunosuppression in melanoma
Anti- cancer therapy: Blazing the trail with melanoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
MCXLI. - MCL.
Selecting inflation indicators under an inflation targeting regime: evidence from the MCL method
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
Drug targeting organ specific strategies
Verbesserung der Zytotoxizität eines TRAIL-exprimierenden onkolytischen Adenovirus in Melanomzellen durch Knockdown des antiapoptotischen Proteins Mcl-1